AeRang Kim, MD, PhD Oncologist

Make an Appointment

View My Research Profile

Locations

Main Hospital Washington, District of Columbia 20010 1-888-884-BEAR (2327)

Languages Spoken

English

Departments

Board Certifications

American Board of Pediatrics
American Board of Pediatrics/Hematology-Oncology

National Provider ID: 1558415224

Bio Specialties Education & Training News Research & Publications

Bio

Biography

AeRang Kim, MD, PhD, is a member of the solid tumor faculty at Children’s National Health System and an Assistant Professor of Pediatrics. Dr. Kim's specializes in sarcomas and developmental therapeutics. Her research focuses on development of novel therapeutics for pediatric cancer including pre-clinical testing of novel agents, pharmacokinetic analysis, developing innovative methods for toxicity monitoring, and clinical trial design. She serves as the principal investigator of multiple early phase trials in pediatric oncology, sarcomas, and NF1 associated tumors.

View My Clinical Trials

Specialties

Education & Training

PhD, 2009
Johns Hopkins School of Public Health
Fellowship Program, Pediatric Hematology/Oncology, 2008
Johns Hopkins Hospital
Residency Program, Pediatrics, 2004
New York University
Internship Program, Pediatrics, 2002
New York Hospital
MD, 2001
University of Illinois at Chicago College of Medicine
BA, 1996
Northwestern University

News

Children’s National and Celsion Announce Clinical Study to Treat Recurrent Childhood Tumors

November 15, 2016

Children’s National and Celsion announce clinical study to treat recurrent childhood tumors using MR-HIFU targeting to apply heat-activated chemotherapy drug

Targeting Tumors More Precisely, With Fewer Lasting Side Effects for Kids

June 06, 2016

Pediatric patients with cancer are often treated with a cocktail of therapies to attack the disease through a variety of mechanisms. While this approach has been instrumental in saving children’s lives, the life-saving therapies can be accompanied by acute side effects, and the treatments may have lingering impacts as cancer survivors enter adulthood.

Children's Oncologist Quoted in Washington Post Article Featuring Patient Using a Robot to Attend School

November 28, 2015

Aerang Kim, MD, PhD, was quoted in this article covering a young patient's experience using a robot in the classroom.

Research & Publications

Characteristics and outcome of pediatric patients enrolled on phase I oncology trials

(2008) The Oncologist

Characteristics of children enrolled on treatment trials for NF1 related plexiform neurofibromas

(2009) Neurology

Sorafenib and Sunitinib

(2009) The Oncologist

The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors

(2008) Pediatric Blood Cancer

View publications on PubMed

Give Act

Invest in future cures for some of life's most devastating diseases

$10 a month

One time donation

See other ways to give

Share your birthday with a child. Celebrate your life, and give a chance to someone who desperately wants to have as many as you.

Make it happen

Christopher's Story

Christopher Melkonian was six years old when he came down with a low-grade fever and diffuse bone pain. Unsure of what was happening, his parents Darlene and David took him to Children’s National Health System and soon found out that Christopher had acute lymphoblastic leukemia (ALL), a type of blood and bone marrow cancer that affects white blood cells.

Children's National in Your Neighborhood

Did you know we have 4 locations in Northern Virginia?

Find a Children's Location Near You